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Background: To evaluate the effectiveness of an experimental intervention based on standard diet recommendations
plus free Smartphone application (app) and wearable device for weight loss, compared with the standard diet
intervention alone, in primary care patients aged 18 years or older who are overweight or obese.
Methods/design: Multicentre randomized, controlled clinical trial. Location: Primary health care centres in the city of
Tarragona and surrounding areas. Subjects: 70 primary care patients, aged 18 years or older, with body mass index of
25 g/m2 or greater who wish to lose weight. Description of the intervention: 12 months of standard diet
recommendations without (n = 35) or with (n = 35) assistance of a free Smartphone app that allows the participant to
maintain a record of dietary intake and a bracelet monitor that records physical activity. The outcomes will be weight
loss at 12 months (primary outcome), changes in physical activity and cardiometabolic risk factors, frequency of app
use, and participant satisfaction after 12 months.
Discussion: The results of our study will offer evidence of the effectiveness of an intervention using one of the most
popular free apps and wearable devices in achieving weight loss among patients who are overweight or obese. If
these new technologies are proven effective in our population, they could be readily incorporated into primary care
interventions promoting healthy weight.
The open design and study characteristics make it impossible for the participants and researchers to be blinded to
study group assignment. Researchers responsible for data analysis will be blinded to participant allocation.
Trial registration: Clinical Register: NCT02417623. Registered 26 March 2015.Background
In Spain, the prevalence of overweight and obesity is
increasing. In 1987, 7.4 % of the adult population (aged
18 years and older) had a body mass index (BMI) of
30 kg/m2 or higher (the cut-off for obesity). In 2012, this
percentage exceeded 17, and 53.7 % of the adult popula-
tion met the definition of obesity or overweight [1]. The
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in overweigh or obesity [2]. Recently, have appeared new
products such as Smartphone applications and wearable
device that may improve these modifiable risk factors
for obesity.
Obesity is clearly associated with increased morbidity
and mortality [3, 4]. As BMI increases, a gradual but
continual increase in relative risk of mortality has been
reported, with the greatest increase observed when BMI
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risk factors for diabetes and cardiovascular disease [6].
Treatments for overweight and obesity obtain dispar-
ate results. In one review of 14 studies of weight-loss
interventions in young adults (18–25 years old), the
authors conclude that combined interventions seem to
have a beneficial effect on weight loss (−2.96 kg,
95%CI −4.4 to −1.5 kg). The most significant weight
reduction was obtained by combining diet, exercise
and motivational strategies [7,8]. Considering the ubiquity
of Smartphone use, mobile applications (apps) that
combine multiple strategies offer an attractive “modern”
alternative to traditional weight-loss programs.
According to the 15th edition of “The Information
Society in Spain”, published in 2015 by the foundation of
Spain’s national phone company, mobile phones are
owned by almost 95.5 % of the world population, and by
almost 120 % of the European population. More than
80 % of mobile phone users have Smartphone and more
tablets than laptop computers are sold as intelligent ter-
minals. The nascent field of mobile health (mHealth) is
rapidly expanding; experts estimate that as many as
100,000 health-related apps were available in the first
trimester of 2014 [9] . Many of these apps aim to help
persons change behaviours to achieve weight loss by
increasing physical activity or recording dietary intake.
According to data from Price Waterhouse Cooper and
GSMA, by 2017 the use of mHealth could save the
health care budgets of European countries up to 100,000
million euros [10]. Interventions in the primary care
setting have the added benefit of ongoing professional
support and monitoring, which could contribute to bet-
ter patient outcomes.
The hypothesis that some overweight and obese sub-
jects do not lose weight while following a low-caloric
diet because their energy intake is substantially higher
than reported is based on the finding that whereas many
people underreporting is greater in overweight and
obese people [11]. Overweight and obese subjects may
also overestimate the energy that may therefore require
less energy intake to maintain body weight than their
exercise history suggests. A study found that the dis-
crepancy between self-reported and actual calorie in-
take and physical activity, estimated as being as large as
47+/−16 % and 51+/−75 %, respectively [12]. Another
study found that consistent self-monitoring of exercise
was associated with fewer difficulties with exercise and
greater exercise and weight loss [13]. This suggests that
providing patients with tools that will help to record
dietary intake or physical activity more accurately could
increase the effectiveness of interventions designed to
prevent overweight/obesity [11, 14]. A study found that
users of a mobile app which self-monitoring physical
activity and dietary intake consumed less energy thanthose self-monitoring using a paper journal [15]. An a
recent systematic review found behavioural changes in-
creased to diet monitoring (p < 0.001) [16].
Unfortunately, many of Smartphone apps are not very
sophisticated and deliver a limited or dubious benefit.
Therefore, the need to regulate this growing market is
becoming a concern, with researchers emphasizing the
need for studies that will contribute scientific evidence
about the true impact of this type of apps . A limited num-
ber of intervention studies have been designed to assess the
effectiveness of Smartphone applications for weight loss
[15, 17–22] and for increase physical activity [15, 20, 23].
All of these studies had small sample sizes, none of them in-
corporated a wearable device, and none of them were done
in a setting resembling the primary care system in Spain.
In recent months, wearable devices have taken the
electronic devices market by storm. They offer process-
ing capacity and Internet connectivity, and of particular
interest to this project are the wearable knows as Smart-
Bands that can monitor physical activity. In the first
quarter of 2014, 2.7 million SmartBands were sold [9].
The SmartBands have adopted gamification as a means
to increase initiation and retention of desired behav-
iours. Gamification is the use of game design elements
in nongame contexts, include the use of game-like re-
wards and incentives and sustain habits of individuals
over time. A comprehensive review of gamification use
in health and fitness found a lack of integrating import-
ant elements of behavioural theory form the app indus-
try, which can potentially impact the efficacy of
gamification apps to change behaviour [24]. Although
the use of this tactic in health and fitness mobile apps
has increased, little to no in-depth inquire into its effect-
iveness and appropriate functionality [24].
Objectives
The objective of the present study is to evaluate the ef-
fectiveness of a weight loss intervention based on stand-
ard diet recommendations plus a free Smartphone
application (app) and wearable device, compared to the
standard evidence-based diet intervention alone (con-
trol), in primary care patients aged 18 years or older
who are overweight or obese.
Methods
Study design
Randomized, controlled trial with one experimental group
and a control group (Participant Flowchart, Fig. 1).
Blinding
The type of intervention makes it impossible to blind
participants and health professionals to participants’
study group assignment. However, those responsible for
data analysis will be blinded to group status.
Fig. 1 Participant Flowchart
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Participants (n = 70) will be recruited from two primary
healthcare centres in the city of Tarragona and sur-
rounding areas and randomly assigned to a standard diet
intervention (control group, n = 35) or standard diet
intervention plus a free Smartphone application and
wearable device (experimental group, n = 35). A per-
sonalized letter will be sent to the attention of the centre
administrators, requesting collaboration and providing a
copy of the study protocol. Within 2 weeks, the adminis-
trators will be contacted by telephone to confirm their
participation.
Patient inclusion criteria: a) Adults aged 18 years or
older with BMI ≥25 kg/m2; b) Medical history available
in the participating primary care centre; c) Access to a
mobile device with Android operating system or iOS;
and d) Consent to participate.
Patient exclusion criteria: a) Morbid obesity, defined
as BMI >40; b) Secondary obesity (e.g., a disease of theendocrine system); c) Eating disorder diagnosed in any
family member (not only the patient); d) Any major co-
morbidity requiring specific treatment (e.g., type 1 dia-
betes mellitus, severe mental disease); i) Women who
are pregnant or want to be pregnant within 12 months;
f ) Participation in a weight-loss program or taking a
weight-loss medication at the time of recruitment; h):
Use of an operating system other than Android or iOS;
and i) No consent to participate.
Sample size
Accepting an alpha risk of 0.05 and a beta risk of 0.2 in
a two-sided test, 70 subjects are necessary in each group,
with an estimated 30 % loss to follow-up, to recognize as
statistically significant a difference greater than or equal
to 3.9 kg [22]. The common standard deviation is as-
sumed to be 4.826 kg.
Screening and randomization
During the recruitment period, and until the calculated
sample size has been achieved, participating primary
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older, for any reason, meeting the study definition of
overweight or obesity will invite the patient to partici-
pate in the study (Fig. 1: Participant Flowchart). If the
patient does not meet any exclusion criteria and agrees
to participate, the health professional will schedule a pri-
mary care visit with a doctor or nurse participating in
the study (Visit 0, screening) within about a week.
During the screening visit, eligible participants will be
assigned a participation code. The randomization unit
will be the individual patient, assigned 1:1 to the experi-
mental or control groups. An independent investigator
will be responsible for generating the allocation se-
quence using non-commercial Epidat 3.0 software. Dur-
ing this same visit, all participants will begin the
standard diet intervention. In addition, experimental
group participants will download the free app, receive a
bracelet monitor (wearable device), and learn to use
them (along with take-home instructions).
Standard diet intervention for weight loss
Both study groups will receive the same standard diet
intervention for weight loss following the primary health
care guidelines [25]. They will see a primary health care
professional every 2 weeks during the first 3 months,
and monthly thereafter. The visits will take place in the
offices of primary care doctors and nurses. The main
objective of the usual diet intervention for weight loss is
to change dietary paterns, rather than focus on changing
specific food choices. The intervention is designed to be
carried out during a 12-month period, with 15 total
visits. The first visit lasts one hour and followed by
15-min monthly visits. Each visit address one item that
is characteristic of a balanced diet, using educational
materials specifically designed for the intervention. Use of
these supporting materials helps to reeducate patients
about dietary intakes as health professionals individualize
the messages based on each person’s specific dietary habits.
Experimental group
The experimental group will receive the standard diet
intervention for weight loss plus free Smartphone app
plus a wearable device. Description of the mobile app:
The app to be tested in the present trial has three
distinct functions: (a) Self-monitoring of food intake,
recorded to help determine the quantity of calories con-
sumed each day, and physical activity, used to establish a
calorie plan adapted to the profile and daily activities of
each participant. The calorie target zone is automatically
adjusted, depending on the individual’s activity through-
out the day; (b) Social networking, which makes it easy
to share experiences and allows comparison of statistical
data (and competition!) with other users, sharing suc-
cesses and encouraging each other; the classificationchart is continuously updated throughout the day;
Description of the wearable device, a bracelet synchro-
nized with the app, that delivers real-time physical activ-
ity statistics “to the wrist and to the app”. The device
poses daily challenges in terms of steps per day or
distance per activity session. It also monitors hours of
sleep and sleep quality.
Control group
Participants in the control group will only receive stand-
ard diet intervention for weight loss.
Training for participating health professionals
To ensure the fidelity of the standard diet intervention,
health professionals will participate in 8 h of targeted
training to review the theoretical concepts supporting
the protocol. The training will be presented by the re-
search team’s experts in nutrition, with the goal of review-
ing and standardizing the messages to study participants
to improve the homogeneity of the intervention.
Pilot test
We will perform a pilot study with 15 participants in
each group.
Data collection
Demographics and medical history
During visit 1 (baseline) and visit 14 (end of follow-up),
an interviewer-guided survey will be completed by the
patient and primary care nurse or doctor and blood tests
will be ordered. The following data will be obtained: (a)
Sociodemographics– sex, birthdate, educational level, pro-
fession and social rank, categorized using the National
Classification of Occupations (Clasificación Nacional de
Ocupaciones [CNO-2011]); (b) History of diseases and use
of toxic substances – tobacco and number of cigarettes
smoked per day, amount (gr) of alcohol consumed per
week, other toxic substances, and usual medication; and
(c) Blood test: complete blood count, renal function, liver
function, lipid profile, glycaemia.
Physical examination
At each study visit, anthropometrics will be recorded by
a primary care nurse or doctor. Body weight will be
measured with the participant dressed in light clothing
with shoes off on a calibrated balance. Waist circumfer-
ence will be measured (to the nearest 0.5 cm) following
a normal exhalation at the mid-point between the
twelfth rib and superior border of the iliac crest. The
average of the last two of three measures will be used to
determine resting blood pressure, measured with an au-
tomated device (Omron HEM 907) in the supine pos-
ition following a 5-min rest.
Granado-Font et al. BMC Public Health  (2015) 15:531 Page 5 of 6Dietary history and physical activity
At baseline (visit 1) and at end of follow-up (visit 14) the
nurse will register food intake using two methods, a vali-
dated food frequency questionnaire [26] and 24-h recall,
to arrive at an average daily energy consumption esti-
mate (in calories) and determine an individualized
dietary pattern. At baseline (visit 1), and at visits 3, 6,
and 12 months (end of follow-up), physical activity will
be measured with two brief validated questionnaires
[27], administered in the participant’s preferred language
(Catalan or Spanish).
Moreover, all participants will encouraged to self-
record their food intake, using the Smartphone in the
experimental group and a traditional paper-based food
diary in the control group. These records will be
reviewed by a nurse at baseline, at 6 and 12 months.
Process measures
We will determine the retention rates by attendance at
follow-up visits. In the experimental group, we will
monitor the average number of entries per week for diet
and physical activity to observe patterns of use.
In addition, we will carry out in-depth interviews with
a subsample of participants as they complete the study
to determine acceptance and satisfaction related to the
Smartphone application, standard diet intervention and
the combination of standard diet intervention with the
app. We will ask an open-ended question about the app’s
ease of use.
Outcomes
The primary outcome will be change in body weight at
3, 6 and 12 months in the experimental group, com-
pared with the control group.
Secondary outcomes, comparing the intervention
group to the control group, will be four-fold: (a) changes
in BMI, waist circumference, and physical activity at 3, 6
and 12 months; (b) changes in cardiometabolic risk
factors such as systolic blood pressure, glucose, total-
cholesterol, LDL-cholesterol, and HDL-cholesterol at
12 months; (c) change in GPT at 12 months; and (d)
change in dietary pattern at 12 months.
Tertiary outcomes will be related to adherence and
satisfaction: (a) adherence to the intervention, measured
by (a1) difference in follow-up visits attended, compared
to possible total, in both groups and (a2) difference in
mean number of days of self-reported diet entries be-
tween groups; (b) frequency of using the app and wear-
able device; (c) satisfaction with Smartphone app and
with standard diet intervention.
Statistical analysis
Analysis will be based on intention to treat. Basal ana-
lysis will determine the comparability of the two studygroups according to the study variables. Quantitative
variables with a normal distribution will be described as
means and standard deviation, or median and interquar-
tile range otherwise, and qualitative variables as percent-
ages and 95 % confidence intervals. Quantitative basal
characteristics will be compared using Student t test and
qualitative variables using Pearson chi-square test.
A hierarchical linear model (HLM) will be used for
longitudinal data, presented as a 2-level hierarchical
structure: level-1 units consist of the repeated measures
for each subject, and level-2 units will be the subject.
HLM allows the estimation of inter-individual differ-
ences in intra-individual change over time by modelling
the variances and co-variances. All covariables that are
significant at p < 0.30 in bivariate analysis will be in-
cluded in the model. This strategy will sufficiently
reduce the probability of leaving relevant variables out of
the model.
Ethical aspects of the study
The study will be conducted in accordance with the
principles of the Helsinki Declaration, as revised and up-
dated, and will follow Spain’s best practice guidelines
(Buena Práctica Clínica). The protocol and all pertinent
documents have been evaluated and approved by our in-
stitute’s ethics committee (Comité Étic de Investigació
Clínica [CEIC], Institut d’Investigació en Atenció Primària
[IDIAP] Jordi Gol). Data confidentiality will be protected
under the Spanish law governing the protection of per-
sonal data (Ley orgánica de Protección de Datos de
Carácter Personal (15/1999 13 December).
Discussion
One of the study limitations is its open design. It is im-
possible to mask the intervention; both patients and
health professionals in the experimental and control
groups will be aware that they are participating in a
weight loss intervention, which could affect the success
or failure of the intervention and has the potential to
introduce bias. Randomization of patients to study
groups will help to achieve a balance in sociodemo-
graphic and anthropometric characteristics, as well as
risk factor profile. Potential confounding factors will be
controlled by applying the appropriate multivariate ana-
lysis. The researcher responsible for the statistical ana-
lysis will be blinded to study group assignments.
Although the study results cannot be applied to all
health-related mobile apps, limiting the external validity
of the study, they will likely be generalizable to apps with
characteristics similar to this free app. Another possible
limitation is the length of the study period. One of the
great challenges to patients who have lost weight is to
maintain the weight loss longer than a year. Based on
the study results, however, follow-up strategies will be
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study period within the framework of the universal pri-
mary care system in Catalonia.
Among the strengths of the study is that this clinical
trial has the potential to provide a validated weight loss
tool that could be very useful to patients accessing pri-
mary health care who want to lose weight. Very few
studies to date have validated the effectiveness of weight
loss apps, and none of them were done in our setting.
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